TUCSON, Ariz., Nov. 19 /PRNewswire/ -- Medipacs, Inc., a Tucson based drug delivery device company announces today the company has been selected to present at the Invest Southwest Capital Conference to be held in Scottsdale, AZ on December 10 and 11, 2008.
One of only 12 companies to present at the conference, Medipacs was selected from 84 submissions in a variety of high-tech fields. "Generally speaking, (the businesses) have to be highly scalable and highly defensible" said Dave Bittner, this year's conference chairman.
Medipacs was founded in 2004 by Mark Banister, a career entrepreneur and was awarded several grants from the National Science Foundation and Science Foundation of Arizona which helped advance fundamentally new polymer science to the point of attracting investor attention. Medipacs' novel polymer gel expands to multiples of its original size. This large expansion ratio occurs precisely and rapidly which enables a variety of practical, low cost drug delivery devices to be used for administering small volume Parenteral (SVP) drugs. According to recent studies, SVP drugs are often implicated in drug delivery errors that extend hospital stays and increase variable costs and Medipacs devices are aimed at reducing many of these errors with its novel delivery systems.
Since June 2007, the company has raised $1.7M from Mesa Verde Ventures, a seed stage venture firm specializing in medical device start-ups in San Diego, CA, and from angel investors in Tucson, San Diego and Washington DC. Mark McWilliams, CEO of Medipacs, has been the co-founder of two drug delivery device companies which brought new drug delivery technologies to market. He has also developed devices and systems serving other medical fields.
Bill Bloom, V.P. Engineering, a Caltech graduate that has worked in the
medical device field for over 35 years and who developed insulin pumps for
Alfred Mann at Mini-Med in th
|SOURCE Medipacs, Inc.|
Copyright©2008 PR Newswire.
All rights reserved